Cartilage metabolism in osteoarthritis and the influence of viscosupplementation and steroid: A review

Acta Radiologica

Volumn 46, Issue 3, 2005, Pages 288-296

  Tehranzadeh, J ^a,b   Booya, F ^a   Root, J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Intraarticular steroid; Osteoarthritis; Viscosupplementation

Indexed keywords

BIODEGRADATION; BIOSYNTHESIS; BONE; DISEASES; JOINTS (ANATOMY); METABOLISM;

INTRARTICULAR STERIOD; OSTEOARTHRITIS; VISCOSUPPLEMENTATION;

CARTILAGE;

CORTICOSTEROID; HYALURONIC ACID;

CARTILAGE; DRUG EFFECT; HIP; HUMAN; INTRAARTICULAR DRUG ADMINISTRATION; KNEE; METABOLISM; METHODOLOGY; OSTEOARTHRITIS; PATHOPHYSIOLOGY; REVIEW; VISCOSITY;

ADRENAL CORTEX HORMONES; CARTILAGE; HIP JOINT; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; KNEE JOINT; OSTEOARTHRITIS; VISCOSITY;

EID: 22844440744     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850510016027     Document Type: Review

References (37)

1. Balazs EA. Analgesic effect of elastoviscous hyaluronan solutions and the treatment of arthritic pain. Cells Tissues Organs 2003:174:49-62.
2. Burns JW, Skinner K, Colt MJ, Burgess L, Rose R, Diamond MP. A hyaluronate based gel for the prevention of postsurgical adhesions: evaluation in two animal species. Fertil Steril 1996;66:814-21.
3. Cohen MD. Hyaluronic acid treatment (viscosupplementation) for OA of the knee. Bull Rheum Dis 1998;47:4-7.
4. Dahlberg L, Lohmander LS, Ryd L. Intraarticular injections of hyaluronan in patients with cartilage abnormalities and knee pain. A one-year double-blind, placebo-controlled study. Arthritis Rheum 1994;37:521-8.
5. Dequeker J, Aerssens J, Luyten FP. Osteoarthritis and osteoporosis: clinical and research evidence of inverse relationship. Aging Clin Exp Res 2003;15:426-39.
6. Dieppe P. Therapeutic targets in osteoarthritis. J Rheumatol, 136-9.
7. Frizziero L, Govoni E, Bacchini P. Intra-articular hyaluronic acid in the treatment of osteoarthritis of the knee: clinical and morphological study. Clin Exp Rheumatol 1998;16:441-9.
8. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Direct medical costs unique to people with arthritis. J Rheumatol 1997;24:719-25.
9. Gabriel SE, Crowson CS, Campion ME, O'Fallon WM. Indirect and nonmedical costs among people with rheumatoid arthritis and osteoarthritis compared with nonarthritic controls. J Rheumatol 1997;24:43-8.
10. Gibbs DA, Merrill EW, Smith KA, Balazs EA. Rheology of hyaluronic acid. Biopolymers 1968;6:777-91.
11. Gogia PP, Brown M, al-Obaidi S. Hydrocortisone and exercise effects on articular cartilage in rats. Arch Phys Med Rehabil 1993;74:463-7.
12. Hagen R. [Charcot-like arthropathy following intraarticular injections of corticosteroids]. Nord Med 1971:85:381.
13. Hammesfahr JF, Knopf AB, Stitik T. Safety of intraarticular hyaluronates for pain associated with osteoarthritis of the knee. Am J Orthop 2003;32:277-83.
14. Kawano T, Miura H, Mawatari T, Moro-Oka T, Nakanishi Y, Higaki H, et al. Mechanical effects of the intraarticular administration of high molecular weight hyaluronic acid plus phospholipid on synovial joint lubrication and prevention of articular cartilage degeneration in experimental osteoarthritis. Arthritis Rheum 2003;48:1923-9.
15. Kellgren JH, Lawrence JS. Radiological assessment of osteo-arthrosis. Ann Rheum Dis 1957;16:494-502.
16. Kramer JS, Yelin EH, Epstein WV. Social and economic impacts of four musculoskeletal conditions. A study using national community-based data. Arthritis Rheum 1983;26:901-7.
17. Kulund DN. The injured runner. Va Med 1985;112:565-80.
18. Lanes SF, Lanza LL, Radensky PW, Yood RA, Meenan RF, Walker AM, et al. Resource utilization and cost of care for rheumatoid arthritis and osteoarthritis in a managed care setting: the importance of drug and surgery costs. Arthritis Rheum 1997;40:1475-81.
19. Laurent C, Hellstrom S, Stenfors LE. Hyaluronic acid reduces connective tissue formation in middle ears filled with absorbable gelatin sponge: an experimental study. Am J Otolaryngol 1986;7:181-6.
20. Lawrence RC, Helmick CG, Arnett FC, Deyo RA, Felson DT, Giannini EH, et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthritis Rheum 1998;41:778-99.
21. Leardini G, Mascia MT, Stisi S, Sandri G, Franceschini M. [Sanitary costs of osteoarthritis]. Reumatismo 2001;53:316-22.
22. Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am 2003;85-A:1197-203.
23. Listrat V, Ayral X, Patarnello F, Bonvarlet JP, Simonnet J, Amor B, et al. Arthroscopic evaluation of potential structure modifying activity of hyaluronan (Hyalgan) in osteoarthritis of the knee. Osteoarthritis Cartilage 1997;5:153-60.
24. Lohmander LS, Dalen N, Englund G, Hamalainen M, Jensen EM, Karlsson K, et al. Intra-articular hyaluronan injections in the treatment of osteoarthritis of the knee: a randomised, double blind, placebo controlled multicentre trial. Hyaluronan Multicentre Trial Group. Ann Rheum Dis 1996;55:424-31.
25. Lussier A, Cividino AA, McFarlane CA, Olszynski WP, Potashner WJ, De Medicis R. Viscosupplementation with hylan for the treatment of osteoarthritis: findings from clinical practice in Canada. J Rheumatol 1996;23:1579-85.
26. MacLean CH, Knight K, Paulus H, Brook RH, Shekelle PG. Costs attributable to osteoarthritis. J Rheumatol 1998;25:2213-8.
27. Madry H, Cucchiarini M, Terwilliger EF, Trippel SB. Recombinant adeno-associated virus vectors efficiently and persistently transduce chondrocytes in normal and osteoarthritic human articular cartilage. Hum Gene Ther 2003;14:393-402.
28. Marlovits S, Kutscha-Lissberg F, Aldrian S, Resinger C, Singer P, Zeller P, et al. [Autologous chondrocyte transplantation for the treatment of articular cartilage defects inf the knee joint: techniques and results]. Radiologe 2004;44:763-72.
29. McDonough AL. Effects of corticosteroids on articular cartilage: a review of the literature. Phys Ther 1982;62:835-9.
30. Moskowitz RW, Davis W, Sammarco J, Mast W, Chase SW. Experimentally induced corticosteroid arthropathy. Arthritis Rheum 1970;13:236-43.
31. Oliveria SA, Felson DT, Reed JI, Cirillo PA, Walker AM. Incidence of symptomatic hand, hip, and knee osteoarthritis among patients in a health maintenance organization. Arthritis Rheum 1995;38:1134-41.
32. Pelletier JP, Martel-Pelletier J, Ghandur-Mnaymneh L, Howell DS, Woessner JF, Jr. Role of synovial membrane inflammation in cartilage matrix breakdown in the Pond-Nuki dog model of osteoarthritis. Arthritis Rheum 1985;28:554-61.
33. Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, et al. A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results. Osteoarthritis Cartilage 2002;10:506-17.
34. Silberberg M, Silberberg R, Hasler M. Fine structure of articular cartilage in mice receiving cortisone acetate. Arch Pathol 1966;82:569-82.
35. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM. Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Joint Surg Am 2004;86-A(3), 538-45.
36. Wobig M, Dickhut A, Maier R, Vetter G. Viscosupplementation with hylan G-F 20: a 26-week controlled trial of efficacy and safety in the osteoarthritic knee. Clin Ther 1998;20:410-23.
37. Yelin E, Callahan LF. The economic cost and social and psychological impact of musculoskeletal conditions. National Arthritis Data Work Groups. Arthritis Rheum 1995;38:1351-62.